small molecule therapeutics for metastatic melanoma (NovoMedix)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesmall molecule therapeutics for metastatic melanoma (NovoMedix)
Drug Alias Namesmall molecule therapeutics for cancer (Novomedix)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovomedix LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovomedix LLC
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A